Abstract
Leishmaniasis is caused by protozoan parasites belonging to the genus Leishmania. According to WHO, leishmaniasis occurs in four continents and is considered to be endemic in 88 countries, 72 of which are developing countries. Intensive effort to investigate novel compounds to counter the parasites that are resistant to existing drug molecules is necessary. This review intends to give an outline of the present state of knowledge on antileishmanial drugs along with molecules that are currently under development as promising drug candidate. A brief discussion on some aspects of associated drug resistance is also considered.
Keywords: Leishmaniasis, parasitic protozoa, amastigote, diffuse cutaneous leishmaniasis (DCL), disseminated, phlebotomine sandfly, Chemotherapy, visceral and cutaneous sites of infection, immunocompromised patient, AIDS
Letters in Drug Design & Discovery
Title:Small Molecules Antileishmanials: A Review
Volume: 9 Issue: 5
Author(s): Akanksha Kulshrestha, Meenakshi Dhanawat, Nirupam Das, Sushant K. Shrivastava
Affiliation:
Keywords: Leishmaniasis, parasitic protozoa, amastigote, diffuse cutaneous leishmaniasis (DCL), disseminated, phlebotomine sandfly, Chemotherapy, visceral and cutaneous sites of infection, immunocompromised patient, AIDS
Abstract: Leishmaniasis is caused by protozoan parasites belonging to the genus Leishmania. According to WHO, leishmaniasis occurs in four continents and is considered to be endemic in 88 countries, 72 of which are developing countries. Intensive effort to investigate novel compounds to counter the parasites that are resistant to existing drug molecules is necessary. This review intends to give an outline of the present state of knowledge on antileishmanial drugs along with molecules that are currently under development as promising drug candidate. A brief discussion on some aspects of associated drug resistance is also considered.
Export Options
About this article
Cite this article as:
Akanksha Kulshrestha, Meenakshi Dhanawat, Nirupam Das, Sushant K. Shrivastava , Small Molecules Antileishmanials: A Review, Letters in Drug Design & Discovery 2012; 9 (5) . https://dx.doi.org/10.2174/157018012800389359
DOI https://dx.doi.org/10.2174/157018012800389359 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Roles of IL-6-gp130 Signaling in Vascular Inflammation
Current Cardiology Reviews Methylenetetrahydrofolate Reductase: Biochemical Characterization and Medical Significance
Current Pharmaceutical Design Antimetastatic Drug, Pharmacologic Challenge and Opportunity
Current Drug Therapy Nicotinic Receptors in Neurodegeneration
Current Neuropharmacology Large A-V Fistula: Pathophysiological Consequences and Therapeutic Perspectives
Current Vascular Pharmacology Dendrimers as an Effective Nanocarrier in Cardiovascular Disease
Current Pharmaceutical Design Therapeutic Potential of 5-HT7 Receptors in Mood Disorders
Current Drug Targets Beta3-Adrenoreceptors in Cardiovasular Diseases: New Roles for an “Old” Receptor
Current Drug Delivery The Antimitotic Potential of PARP Inhibitors, An Unexplored Therapeutic Alternative
Current Topics in Medicinal Chemistry Endothelin and Oxidative Stress in the Vascular System
Current Vascular Pharmacology Magnetic Resonance Contrast Media Sensing In Vivo Molecular Imaging Agents: An Overview
Current Radiopharmaceuticals New 1-phthalazinone Scaffold based Compounds: Design, Synthesis, Cytotoxicity and Protein Kinase Inhibition Activity
Mini-Reviews in Medicinal Chemistry Targeting Epigenetic Modifiers: Promising Strategies for Cancer Therapy and Beyond
Current Drug Therapy Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other Dysfunctions
Endocrine, Metabolic & Immune Disorders - Drug Targets Transcatheter Aortic Valve Implantation Infective Endocarditis: Current Data and Implications on Prophylaxis and Management
Current Pharmaceutical Design Attenuating Diabetes: What Really Works?
Current Diabetes Reviews Anti-Inflammatory and Antioxidant Properties of Piper Species: A Perspective from Screening to Molecular Mechanisms
Current Topics in Medicinal Chemistry Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today
Current Pharmaceutical Design Folic Acid, Neurodegenerative and Neuropsychiatric Disease
Current Molecular Medicine The Guinea Pig as an Animal Model for Asthma
Current Drug Targets